World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
USA
2023

D-Index & Metrics

Best Scientists

D-Index
184
Citations
134918
World Ranking
527
National Ranking
340

Medicine

D-Index
195
Citations
147761
World Ranking
215
National Ranking
144

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in United States Leader Award

Overview

Jorge E. Cortes is affiliated with Augusta University in the United States and has a research portfolio spanning engineering and computer science. Their work predominantly focuses on control and systems engineering and electrical and electronic engineering, with significant contributions in computer networks and communications, artificial intelligence, and statistical and nonlinear physics.

The scientist's main research topics include advanced control systems optimization, distributed control in multi-agent systems, control systems and identification, microgrid control and optimization, stability and control of uncertain systems, model reduction and neural networks, and gene regulatory network analysis.

Jorge E. Cortes has published extensively in several academic venues. Frequent publication outlets include:

  • arXiv (Cornell University)
  • IEEE Transactions on Automatic Control
  • IEEE Transactions on Control Systems Technology
  • IEEE Control Systems Letters
  • IEEE Transactions on Control of Network Systems

Their recent papers feature contributions to robotics, control systems, and energy resource management. Selected recent publications are:

  • "Learning Barrier Functions With Memory for Robust Safe Navigation," 2021, IEEE Robotics and Automation Letters
  • "Safety-Critical Event Triggered Control via Input-to-State Safe Barrier Functions," 2020, IEEE Control Systems Letters
  • "Frequency Regulation With Heterogeneous Energy Resources: A Realization Using Distributed Control," 2021, IEEE Transactions on Smart Grid
  • "Control-Barrier-Function-Based Design of Gradient Flows for Constrained Nonlinear Programming," 2023, IEEE Transactions on Automatic Control
  • "A Nonsmooth Approach to Controller Synthesis for Boolean Specifications," 2020, IEEE Transactions on Automatic Control

Collaborations form an important part of Jorge E. Cortes's research activities. Frequent co-authors include Thomas Parisini, João P. Hespanha, Andrew G. Alleyne, Sònia Martínez, and Miroslav Krstić.

Best Publications

  • European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Michele Baccarani;Michael W. Deininger;Gianantonio Rosti;Andreas Hochhaus

  • Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

    Moshe Talpaz;Neil P. Shah;Hagop M Kantarjian;Nicholas Donato

  • A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

    Jan Cools;Jan Cools;Daniel J. DeAngelo;Jason Gotlib;Elizabeth H. Stover

  • Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia.

    Hagop Kantarjian;Neil P. Shah;Andreas Hochhaus;Jorge Cortes

  • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Michele Baccarani;Giuseppe Saglio;John Goldman;Andreas Hochhaus

  • Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    Michele Baccarani;Jorge Cortes;Fabrizio Pane;Dietger Niederwieser

  • Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.

    Hagop M Kantarjian;Francis Giles;Lydia Wunderle;Kapil Bhalla

  • Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

    Michael J. Keating;Susan O'Brien;Maher Albitar;Susan Lerner

  • A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

    Jorge E. Cortes;D. W. Kim;J. Pinilla-Ibarz;P. Le Coutre

  • Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies.

    Jean Pierre J. Issa;Guillermo Garcia-Manero;Francis J. Giles;Rajan Mannari

  • Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

    Hagop Kantarjian;Yasuhiro Oki;Guillermo Garcia-Manero;Xuelin Huang

  • Search for new phenomena in final states with an energetic jet and large missing transverse momentum in pp collisions at TeV with the ATLAS detector

    Unknown

  • Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia

    Hagop M Kantarjian;Susan O'Brien;Terry L. Smith;Jorge E Cortes

  • Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

    Amie S. Corbin;Amie S. Corbin;Anupriya Agarwal;Marc Loriaux;Jorge Cortes

  • Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

    Constantine S. Tam;Susan O'Brien;William Wierda;Hagop Kantarjian

  • Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

    Jorge E Cortes;Hagop M Kantarjian;Neil P. Shah;Dale Bixby

  • Molecular biology of bcr-abl1-positive chronic myeloid leukemia

    Alfonso Quintás-Cardama;Jorge Cortes

  • Measurement of production with a veto on additional central jet activity in pp collisions at TeV using the ATLAS detector

    Unknown

  • Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

    Hagop M. Kantarjian;Neil P. Shah;Jorge E. Cortes;Michele Baccarani

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

Frequent Co-Authors

Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Farhad Ravandi
Farhad Ravandi The University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero
Guillermo Garcia-Manero The University of Texas MD Anderson Cancer Center
Elias Jabbour
Elias Jabbour The University of Texas MD Anderson Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine
Gautam Borthakur
Gautam Borthakur The University of Texas MD Anderson Cancer Center
Sherry Pierce
Sherry Pierce The University of Texas MD Anderson Cancer Center
Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center
Marina Konopleva
Marina Konopleva The University of Texas MD Anderson Cancer Center
Naval Daver
Naval Daver The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering alternative pathways in healthcare? Many students explore online nursing programs as a flexible way to advance their careers. One important factor is how much does online nursing school cost—tuition and fees can vary significantly, making affordability a top concern.

Those aiming for leadership or specialized nursing roles may look into online nursing doctoral programs, which can open doors to research and academic positions. Meanwhile, registered nurses seeking career mobility often benefit from affordable rn to bsn programs that expand clinical skills and earning potential.

Non-nurses interested in rapid entry to advanced nursing roles may consider direct entry msn programs online. These programs are designed for career changers and can offer a streamlined route to a master’s degree in nursing.

Each pathway has its own benefits, requirements, and financial considerations. Researching program specifics, eligibility, and costs can help you find the best option to meet your educational and career goals in medicine or nursing.

Best Scientists Citing Jorge E. Cortes

Trending Scientists

Recently Published Articles